Sat.Mar 22, 2025 - Fri.Mar 28, 2025

article thumbnail

AI in Pharma Marketing: Innovation or Compliance Nightmare?

Pharma Marketing Network

Artificial intelligence (AI) is no longer a futuristic concept in healthcareits here, embedded in nearly every touchpoint of modern pharma marketing. From generative AI tools that draft emails to predictive algorithms that segment target audiences, the speed and scale of innovation are staggering. But as pharma marketers race to adopt these tools, a central question looms: Is AI fueling smarter engagement, or setting the stage for a compliance disaster?

HIPAA 52
article thumbnail

Opinion: Former HHS Secretary Donna Shalala on the agency’s ‘silly new bureaucracy’

STAT

When I was secretary of the Department of Health and Human Services under President Bill Clinton, an agency head came to me with a dramatic reorganization plan. I advised him that unless it was data- and outcome-driven, he was wasting his time. Just as important, the reorganization would unsettle and confuse his new colleagues. As a result, his legacy would be a new structure rather than improving people’s lives.

346
346
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

The industry heavyweight behind Novavax’s push to bounce back

PharmaVoice

As it returns from the brink, the vaccine developer has brought in Dr. Ruxandra Draghia-Akli — and her industry and public health chops — to lead R&D.

Vaccines 285
article thumbnail

Brexit a key factor in worst UK medicine shortages in four years, report says

The Guardian - Pharmaceutical Industry

Nuffield Trust says supply chains have shifted, with drugs for epilepsy and cystic fibrosis among those now scarce Drug shortages in the UK have risen to their worst level for four years, official figures show, with Brexit considered a key reason so many medications are scarce. Drug companies notified the Department of Health and Social Care (DHSC) about disruptions to supply 1,938 times during last year the highest number since the 1,967 seen in 2021.

112
112
article thumbnail

Navigating Payroll Compliance: Future-Proofing Payroll in an Evolving Regulatory Landscape

Speaker: Jennifer Hill

Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.

article thumbnail

FDA approves first-in-class oral antibiotic

European Pharmaceutical Review

The US Food and Drug Administration (FDA) has approved Blujepa ( gepotidacin ) antibiotic for uncomplicated urinary tract infections (uUTIs) in female adults and paediatric patients aged 12 years old and over. The first-in-class bactericidal drug is indicated for such infections caused by E scherichia coli, Klebsiella pneumoniae, Citrobacter freundii complex, Staphylococcus saprophyticus and Enterococcus faecalis.

86

More Trending

article thumbnail

RPS to become Royal College of Pharmacy after member vote

The Pharmacist

Members of the Royal Pharmaceutical Society (RPS) have voted in favour of proposed changes that will see it become a Royal College. A third of RPS members turned out to vote, at 6,144 voters from a total of 19,594 eligible. Of those, 71.1% (4,369 members) voted to confirm the proposed changes to the RPS's Royal […] The post RPS to become Royal College of Pharmacy after member vote appeared first on The Pharmacist.

82
article thumbnail

DoP hosts industry dialogue on promotion of research and innovation in pharma-medtech sector scheme

Express Pharma

The Department of Pharmaceuticals, Government of India, hosted an Industry Dialogue on the scheme for the Promotion of Research and Innovation in the Pharma-MedTech Sector (PRIP) in Bangalore on 25th March 2025. The event served as a platform for representatives from industry, startups, and research institutes, including representatives from the Indian Council for Medical Research (ICMR), Council of Scientific and Industrial Research (CSIR), and innovation hubs like C-CAMP (Centre for Cellular a

76
article thumbnail

FDA’s ‘mixed signals’ on diversity have entangled clinical trials. Here’s how pharma can push ahead.

PharmaVoice

The agency is still unclear about where it will stand on clinical trial diversity, but companies are looking for answers and leaning toward good science.

147
147
article thumbnail

Cassidy says RFK Jr. briefed him on HHS job cuts, but reported study on vaccines, autism didn’t come up

STAT

WASHINGTON — Sen. Bill Cassidy, the chairman of the Senate health committee, voted to confirm Robert F. Kennedy Jr. as the nation’s health secretary last month on the condition that Kennedy, a longtime vaccine critic, keep him apprised of agency actions, especially those related to vaccines.  On Thursday morning, Cassidy said, the two had breakfast to discuss Kennedy’s plans to lay off 10,000 Health and Human Services Department employees.

Vaccines 359
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Community pharmacy negotiations concluded, announcement set for Monday

The Pharmacist

Community pharmacy funding negotiations have concluded, with the deal set to be announced on Monday, Community Pharmacy England has said. It comes as the economic analysis of community pharmacy has been published, which was due to happen after negotiations concluded. In response, CPE told The Pharmacist: 'Now that CPCF [Community Pharmacy Contractual Framework] negotiations have […] The post Community pharmacy negotiations concluded, announcement set for Monday appeared first on The Pharma

article thumbnail

FDA grants fast track designation to chlamydia vaccine candidate

Pharmafile

The US Food and Drug Association (FDA) has granted fast track designation to Sanofis mRNA vaccine candidate for the prevention of chlamydia infection. The chlamydia vaccine candidate has been designed to protect against primary genital tract infection and reinfection caused by the bacterium Chlamydia trachomatis. Sanofi is an international pharma and healthcare company, providing vaccination […] The post FDA grants fast track designation to chlamydia vaccine candidate appeared first on Pha

article thumbnail

How Has Social Media Advertising Changed in Pharma

Pharma Marketing Network

Introduction Social media advertising has undergone a major transformation in the pharmaceutical industry over the past decade. What once was a cautious, slow-moving experiment has now become a vital component of modern pharma marketing strategies. The increasing integration of platforms like LinkedIn, X (formerly Twitter), YouTube, and even TikTok has dramatically shifted how pharma brands engage with healthcare professionals (HCPs), patients, and caregivers.

HIPAA 52
article thumbnail

STAT+: 23andMe’s bankruptcy is the worst thing that could happen to just about everyone involved

STAT

How did 23andMe go bankrupt? The same way bankruptcy was described by Ernest Hemingway in 1926: “Two ways: Gradually, and then suddenly.” Since its founding in 2006, the company, which aimed to give consumers access to their genetic information, faced what seemed like one killing blow after another: questions of whether its business was ethical, the Food and Drug Administration blocking the sale of its tests, and, last year, a cyberattack in which hackers gained access to the recor

362
362
article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

Rx-to-OTC rule gets pushed back — again

PharmaVoice

A delay of the prescription-to-OTC rule signals health agencies’ ongoing reluctance to implement new regulations.

147
147
article thumbnail

Cell and gene therapy market set to grow at 44% CAGR through 2030: GlobalData

Express Pharma

The global cell and gene therapy (CGT) market is poised for exceptional growth at a compound annual growth rate of 44 per cent, with sales projected to rise from $8.70 billion in 2024 to $76.03 billion in 2030. Significant advancements in treatments for gastrointestinal (GI) disorders are anticipated, driven by innovations from both large and small pharma companies, says GlobalData, a leading data and analytics company.

article thumbnail

Is my Pharma Marketing Job Going to Be Eliminated?

Pharma Marketing Network

Automation, AI, budget cuts, and evolving digital strategies have prompted a growing question among pharmaceutical marketing teams: Is my pharma marketing job at risk? As companies adapt to more agile workflows and redefine what modern commercialization looks like, the roles of marketing professionals are being evaluated more critically than ever before.

59
article thumbnail

State and local health departments grapple with flurry of cuts from D.C.

STAT

Food programs in poor neighborhoods. People to track surges of Covid, measles, or other diseases. Programs to help people with addiction. The cascade of budget cuts from Washington has hundreds of state and local health officials around the country struggling to assess the impact on their communities and departments.

327
327
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

FDA Approves Fresenius’s Denosumab Biosimilars

Big Molecule Watch

On March 26, 2025, the FDA approved Fresenius Kabis denosumab biosimilars, CONEXXENCE (denosumab-bnht) and BOMYNTRA (denosumab-bnht), referencing Amgens PROLIA and XGEVA, respectively. These approvals make Fresenius the fourth company to receive FDA approval for a pair of denosumab biosimilars, joining Celltrion , Samsung , and Sandoz. Denosumab is a RANK ligand (RANKL) inhibitor that is used to treat bone loss.

article thumbnail

AdjuTec Pharma, Venus Remedies initiate research collaboration to evaluate APC-148 against AMR

Express Pharma

AdjuTec Pharma AS, a privately held company developing antibiotic resistance breakers, announces that it has entered into a research collaboration agreement with Venus Remedies. Venus Remedies will perform a pre-clinical evaluation of AdjuTec Pharmas APC-148 platform technology. AdjuTec Pharma has developed novel inhibitor technologies that selectively destroy antibiotic resistance mechanisms in multidrug-resistant bacteria, thereby restoring the effectiveness of commercially available antibioti

66
article thumbnail

HHS to cut 10,000 staff in major restructuring under RFK Jr.

BioPharma Dive

The FDA will lose about 3,500 employees under the plans, although HHS said drug, medical device and food reviewers will not be affected.

131
131
article thumbnail

At meeting on guardrails for gene editing of human embryos, some call for a dead end

STAT

WASHINGTON — Keith Joung knows better than a lot of people what, exactly, it might require to prove to regulators and patients that CRISPR could be safely used to alter the genome of a human embryo. If, of course, society decided that was a good idea. Joung, an early pioneer of the gene-editing technology, was the first to show CRISPR could target and cut DNA inside an embryo — in zebrafish — back in 2013.

333
333
article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

Weekends: Perfect time to catch up on the Pharma Marketing Network

Pharma Marketing Network

Introduction Weekends may be synonymous with relaxation, but for pharma marketing professionals, they offer an unmatched window to recalibrate. When deadlines arent looming and inboxes arent overflowing, theres finally time to revisit trends, read strategy insights, and uncover tools to elevate your marketing game. The Pharma Marketing Network serves as an ideal destination for this kind of weekend deep-dive.

59
article thumbnail

HHS announces sweeping reorganization, including cuts of 10K workers

PharmaVoice

Along with shrinking the HHS’ workforce further, the reorganization announced Thursday will cut the department from 28 divisions to 15, and close five regional offices.

130
130
article thumbnail

First Prader-Willi drug to reduce hunger approved by FDA

BioPharma Dive

Clearance of Vykat unlocks what analysts anticipate will be a lucrative market opportunity for Soleno Therapeutics.

127
127
article thumbnail

Opinion: 23andMe’s bankruptcy doesn’t diminish its impact

STAT

23andMe might have filed for bankruptcy , but the transformation it brought to health care over nearly two decades is irreversible. I’m a physician, scientist, and advocate for public health. I’ve witnessed how empowering people with knowledge about their own biology drives meaningful health decisions and actions, something millions have now experienced firsthand.

347
347
article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

article thumbnail

The Healthcare Businesswomen’s Association (HBA) Announces its 2025 Rising Star and Luminary Honorees

Pharma Marketing Network

The Healthcare Businesswomens Association (HBA) has proudly announced its 2025 class of Rising Star and Luminary honorees! Nominated by the HBAs Corporate Partners, these leaders are not only exceptional contributors within their companies but also powerful advocates for health equity and women’s advancement globally, significantly contributing to the HBAs vision of Creating Women Leaders for Life.

article thumbnail

How AZ and Amgen’s Tezspire respiratory data ups the ‘level of ambition’ in immunology

PharmaVoice

After Tezspire reduced the need for nasal polyp surgery by 98% in patients with a severe respiratory condition, the biopharma giants are even more ambitious for the next wave of biologic medicines.

130
130
article thumbnail

Shift to automated and sustainable options shaping environmental monitoring market

European Pharmaceutical Review

The global pharmaceutical & biotechnology environmental monitoring market is expected to expand with a CAGR of 6.2 percent between 2025 and 2031, according a report by Lucintel. Several factors are fuelling this growth, including greater adoption of advanced innovations such as cloud technology, which are driving efficiencies and accuracy, the research highlighted.

59